Osteoporosis global clinical trials review
Upcoming SlideShare
Loading in...5
×
 

Osteoporosis global clinical trials review

on

  • 477 views

GlobalData’s “Osteoporosis Global Clinical Trials Review, H2, 2011” is now available at Marketreportsonline.com.

GlobalData’s “Osteoporosis Global Clinical Trials Review, H2, 2011” is now available at Marketreportsonline.com.

Statistics

Views

Total Views
477
Views on SlideShare
477
Embed Views
0

Actions

Likes
0
Downloads
3
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Osteoporosis global clinical trials review Osteoporosis global clinical trials review Document Transcript

  • Osteoporosis Global Clinical Trials Review, H2, 2011Published:October 2011No. of Pages:117Price: 1000GlobalDatas clinical trial report, “Osteoporosis Global Clinical Trials Review, H2, 2011" provides dataon the Osteoporosis clinical trial scenario. This report provides elemental information and data relatingto the clinical trials on Osteoporosis. It includes an overview of the trial numbers and theirrecruitment status as per the site of trial conduction across the globe. The databook offers apreliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsorsand also provides briefing pertaining to the number of trials for the key drugs for treatingOsteoporosis. This report is built using data and information sourced from proprietary databases,primary and secondary research and in-house analysis by GlobalDatas team of industry experts.Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe,Middle-East and Africa and Asia-pacific and top five national contributions in each, along with theclinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsortype- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsortype and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesTable of ContentsTable of Contents 2List of Tables 5List of Figures 7Introduction 8Osteoporosis 8Report Guidance 8Clinical Trials by Region 9Clinical Trials by Country 10Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13Top Countries Contributing to Clinical Trials in North America 14Top Countries Contributing to Clinical Trials in Middle East and Africa 15Top Five Countries Contributing to Clinical Trials in Central and South America 16Clinical Trials by BRIC Nations 17Clinical Trials by G7 Nations 18Clinical Trials in G7 Nations by Trial Status 19Clinical Trials by E7 Nations 20Clinical Trials in E7 Nations by Trial Status 21Clinical Trials by Phase 22In Progress Trials by Phase 23Clinical Trials by Trial Status 24Unaccomplished Trials of Osteoporosis 25Subjects Recruited Over a Period of Time 29Prominent Sponsors 30Top Companies Participating in Osteoporosis Therapeutics Clinical Trials 32Prominent Drug Comparison 34Clinical Trial Profiles 35Clinical Trial Overview of Top Companies 35Merck & Co., Inc. 35Clinical Trial Overview of Merck & Co., Inc. 35Novartis AG 37Clinical Trial Overview of Novartis AG 37Eli Lilly and Company 39Clinical Trial Overview of Eli Lilly and Company 39Amgen Inc. 41Clinical Trial Overview of Amgen Inc. 41GlaxoSmithKline plc 43Clinical Trial Overview of GlaxoSmithKline plc 43Pfizer Inc. 44Clinical Trial Overview of Pfizer Inc. 44Sanofi 45Clinical Trial Overview of Sanofi 45NPS Pharmaceuticals, Inc. 46Clinical Trial Overview of NPS Pharmaceuticals, Inc. 46F. Hoffmann-La Roche Ltd. 47Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 47AstraZeneca PLC 48Clinical Trial Overview of AstraZeneca PLC 48Ono Pharmaceutical Co., Ltd. 49Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 49Warner Chilcott Plc 50
  • Clinical Trial Overview of Warner Chilcott Plc 50Ligand Pharmaceuticals, Inc. 51Clinical Trial Overview of Ligand Pharmaceuticals, Inc. 51Astellas Pharma Inc. 52Clinical Trial Overview of Astellas Pharma Inc. 52Chugai Pharmaceutical Co., Ltd. 53Clinical Trial Overview of Chugai Pharmaceutical Co., Ltd. 53Bayer AG 54Clinical Trial Overview of Bayer AG 54Radius Health, Inc. 55Clinical Trial Overview of Radius Health, Inc. 55Medtronic Spine LLC 56Clinical Trial Overview of Medtronic Spine LLC 56Cephalon, Inc. 57Clinical Trial Overview of Cephalon, Inc. 57Daiichi Sankyo Company, Ltd 58Clinical Trial Overview of Daiichi Sankyo Company, Ltd 58Clinical Trial Overview of Top Universities / Institutes / Hospitals 59University of Pittsburgh 59Clinical Trial Overview of University of Pittsburgh 59University of Wisconsin Madison 60Clinical Trial Overview of University of Wisconsin Madison 60University of Alabama at Birmingham 61Clinical Trial Overview of University of Alabama at Birmingham 61Purdue University 62Clinical Trial Overview of Purdue University 62University of Alberta 63Clinical Trial Overview of University of Alberta 63Northwestern University 64Clinical Trial Overview of Northwestern University 64Aarhus University 65Clinical Trial Overview of Aarhus University 65Odense University Hospital 66Clinical Trial Overview of Odense University Hospital 66The National Institute of Diabetes and Digestive and Kidney Diseases 67Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 67Mayo Clinic 68Clinical Trial Overview of Mayo Clinic 68INSTITUT DE RECHERCHES INTERNATIONALES SERVIER 69Clinical Trial Overview of INSTITUT DE RECHERCHES INTERNATIONALES SERVIER 69Maastricht University Medical Center 70Clinical Trial Overview of Maastricht University Medical Center 70
  • Massachusetts General Hospital 71Clinical Trial Overview of Massachusetts General Hospital 71Tufts University 72Clinical Trial Overview of Tufts University 72Columbia University 73Clinical Trial Overview of Columbia University 73University of Saskatchewan 74Clinical Trial Overview of University of Saskatchewan 74U.S. Department of Veterans Affairs 75Clinical Trial Overview of U.S. Department of Veterans Affairs 75University Health Network 76Clinical Trial Overview of University Health Network 76The University of Sydney 77Clinical Trial Overview of The University of Sydney 77Oregon Health and Science University 78Clinical Trial Overview of Oregon Health and Science University 78Five Key Clinical Profiles 79Appendix 113Abbreviations 113Definitions 113Research Methodology 115Secondary Research 115About GlobalData 116Contact Us 116Disclaimer 116Source 117About Us:MarketReportsOnline is comprising of an online library of 50,000 reports, in-depth market researchstudies of over 5000 micro markets, and 25 industry specific websites. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market research reports.Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: + 1 888 391 5441E-mail: sales@marketreportsonline.comhttp://marketreportsonline.com/